and (iv) annual cash bonuses under the Companys bonus program, with a target bonus opportunity equal to 75% of Mr. Suidans annual base salary. The payment of any annual
bonus, to the extent any such bonus becomes payable, will be contingent upon Mr. Suidans continued employment through the applicable payment date, and will be pro-rated for any partial year of
employment.
In connection with entering into the offer letter, Mr. Suidan was granted an option to purchase shares of our Class A Common Stock,
as well as an award of RSUs, under the 2021 Plan. The awards each have an aggregate dollar-denominated grant-date value equal to approximately $1,000,000. Each award will vest and, as applicable, become exercisable, as to 25% of the shares
underlying the award on each of the first four anniversaries of the grant date, subject to Mr. Suidans continued employment through the applicable vesting date.
The severance benefits and payments payable to Mr. Suidan upon certain qualifying terminations of his employment are summarized below under the section
entitled, Potential Payments Upon Termination or Change in Control.
As a condition to Mr. Suidans employment under
the Offer Letter, Mr. Suidan also entered into the Companys standard form of Confidentiality and Non-Solicitation Agreement and a Dispute Resolution Agreement.
Michael Neimand
On August 30, 2006, we entered into
an offer letter with Michael Neimand. Mr. Neimands employment under the offer letter is at-will and will continue until terminated at any time by either party.
The severance benefits and payments payable to Mr. Neimand upon a qualifying termination of his employment are summarized below under the section
entitled, Potential Payments Upon Termination or Change in Control.
In connection with his offer letter, Mr. Neimand also
entered into the Companys standard form of confidentiality agreement.
Kathy Vrabeck
On March 27, 2021, we entered into an employment offer letter with Ms. Vrabeck to serve as our Chief Strategy Officer. Ms. Vrabecks
employment under the offer letter, which began on April 26, 2021, is at-will and will continue until terminated at any time by either party. Pursuant to the offer letter, Ms. Vrabeck is entitled to
receive an annual base salary of $525,000 per year. In addition, Ms. Vrabeck (and her beneficiaries) are eligible to participate in the health and welfare benefit plans and programs maintained by us for the benefit of our employees, the full
cost of which is paid by the Company.
Under the offer letter, Ms. Vrabeck is also eligible to earn annual cash bonuses under our bonus program, with
an annual target bonus opportunity equal to 67% of her base salary; Ms. Vrabecks 2023 target bonus opportunity was equal to 75% of her base salary. The payment of any annual bonus, to the extent any such bonus becomes payable, will be
contingent upon Ms. Vrabecks continued employment through the applicable payment date.
In connection with entering into the offer letter,
Ms. Vrabeck was awarded options and/or RSUs having an aggregate grant-date fair value of approximately $2,300,000. The awards will vest annually over four years, with respect to 25% of the shares underlying the award on each of the first four
anniversaries of April 26, 2021, subject to continued employment. The severance benefits and payments payable to Ms. Vrabeck upon certain qualifying terminations of her employment are summarized below under the section entitled,
Potential Payments Upon Termination or Change in Control.
In connection with her offer letter, Ms. Vrabeck also entered
into the Companys standard form of confidentiality agreement and arbitration agreement.
36